Within IDH wild-type gliomas, the higher hypoxia associated with EGFR amplification may be explained by two mechanisms: the translational up-regulation of EGFR induced by hypoxic microenvironment [38] and the enhanced oncogenic pathways downstream to increased EGFR activation [39]. The gene discussed is EGFR; the disease is central nervous system cancer.